These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 12209699

  • 1. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.
    Meric F, Hess KR, Varma DG, Hunt KK, Pisters PW, Milas KM, Patel SR, Benjamin RS, Plager C, Papadopoulos NE, Burgess MA, Pollock RE, Feig BW.
    Cancer; 2002 Sep 01; 95(5):1120-6. PubMed ID: 12209699
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
    Pappo AS, Devidas M, Jenkins J, Rao B, Marcus R, Thomas P, Gebhardt M, Pratt C, Grier HE.
    J Clin Oncol; 2005 Jun 20; 23(18):4031-8. PubMed ID: 15767644
    [Abstract] [Full Text] [Related]

  • 3. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ, Xu F, Wang SS, Luo HY, Wang F, Li FH, Sun XF, Xu GC, Lin TY, Huang HQ, Jiang WQ, Guan ZZ, Xu RH.
    Ai Zheng; 2007 Dec 20; 26(12):1344-9. PubMed ID: 18076798
    [Abstract] [Full Text] [Related]

  • 4. Neoadjuvant chemotherapy for intermediate/high-grade soft tissue sarcomas: five-year results with epirubicin and ifosfamide.
    Ottaiano A, De Chiara A, Fazioli F, De Rosa V, Ravo V, Boccia V, Botti G, Petrillo A, Fiore F, Mori S, Mozzillo N, Iaffaioli VR, Apice G.
    Anticancer Res; 2002 Dec 20; 22(6B):3555-9. PubMed ID: 12552955
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma.
    Menendez LR, Ahlmann ER, Savage K, Cluck M, Fedenko AN.
    Clin Orthop Relat Res; 2007 Feb 20; 455():219-24. PubMed ID: 17016226
    [Abstract] [Full Text] [Related]

  • 6. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
    Lucas DR, Kshirsagar MP, Biermann JS, Hamre MR, Thomas DG, Schuetze SM, Baker LH.
    Oncologist; 2008 Apr 20; 13(4):451-8. PubMed ID: 18448561
    [Abstract] [Full Text] [Related]

  • 7. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
    King JJ, Fayssoux RS, Lackman RD, Ogilvie CM.
    Am J Clin Oncol; 2009 Jun 20; 32(3):308-13. PubMed ID: 19433963
    [Abstract] [Full Text] [Related]

  • 8. Caffeine-potentiated chemotherapy for patients with high-grade soft tissue sarcoma: long-term clinical outcome.
    Takeuchi A, Tsuchiya H, Yamamoto N, Hayashi K, Yamauchi K, Kawahara M, Miyamoto K, Tomita K.
    Anticancer Res; 2007 Jun 20; 27(5B):3489-95. PubMed ID: 17972506
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
    Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL.
    Cancer; 2003 May 15; 97(10):2530-43. PubMed ID: 12733153
    [Abstract] [Full Text] [Related]

  • 10. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M, Chu Q, Burton G, Ampil F, Mizell J, Li BD.
    Am Surg; 2005 Jun 15; 71(6):487-92. PubMed ID: 16044927
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment and prognosis of 33 patients with recurrent retroperitoneal soft tissue sarcomas].
    Cai J, Shao Y, Yu H, Chen K, Jiang Y.
    Zhonghua Wai Ke Za Zhi; 1998 Nov 15; 36(11):671-3. PubMed ID: 11825495
    [Abstract] [Full Text] [Related]

  • 14. Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).
    Stahl R, Wang T, Lindner LH, Abdel-Rahman S, Santl M, Reiser MF, Issels RD.
    Int J Hyperthermia; 2009 Jun 15; 25(4):289-98. PubMed ID: 19670096
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R, Osaki A, Tanabe K, Toge T.
    Oncol Rep; 2004 Jun 15; 11(6):1265-72. PubMed ID: 15138565
    [Abstract] [Full Text] [Related]

  • 16. Surgical management of soft tissue sarcomas of the hand and foot.
    Lin PP, Guzel VB, Pisters PW, Zagars GK, Weber KL, Feig BW, Pollock RE, Yasko AW.
    Cancer; 2002 Aug 15; 95(4):852-61. PubMed ID: 12209730
    [Abstract] [Full Text] [Related]

  • 17. Preoperative doxorubicin plus ifosfamide in primary soft-tissue sarcomas of the extremities.
    Azzarelli A, Quagliuolo V, Casali P, Fissi S, Montalto F, Santoro A.
    Cancer Chemother Pharmacol; 1993 Aug 15; 31 Suppl 2():S210-2. PubMed ID: 8453700
    [Abstract] [Full Text] [Related]

  • 18. Caffeine-potentiated radiochemotherapy and function-saving surgery for high-grade soft tissue sarcoma.
    Tsuchiya H, Yamamoto N, Asada N, Terasaki T, Kanazawa Y, Takanaka T, Nishijima H, Tomita K.
    Anticancer Res; 2000 Aug 15; 20(3B):2137-43. PubMed ID: 10928167
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas.
    Ferrari A, Brecht IB, Koscielniak E, Casanova M, Scagnellato A, Bisogno G, Alaggio R, Cecchetto G, Catania S, Meazza C, Int-Veen C, Kirsch S, Dantonello T, Carli M, Treuner J.
    Pediatr Blood Cancer; 2005 Aug 15; 45(2):128-34. PubMed ID: 15852434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.